50 results on '"Pae, Chi-Un"'
Search Results
2. Reduced CXCL1/GRO chemokine plasma levels are a possible biomarker of elderly depression
3. Sickness absence indicating depressive symptoms of working population in South Korea
4. Modafinil for the treatment of attention-deficit/hyperactivity disorder: A meta-analysis
5. Aripiprazole augmentation versus antidepressant switching for patients with major depressive disorder: A 6-week, randomized, rater-blinded,prospective study
6. Vortioxetine, a multimodal antidepressant for generalized anxiety disorder: A systematic review and meta-analysis
7. The potential role of atypical antipsychotics for the treatment of posttraumatic stress disorder
8. A Bibliometric Study on Second-generation Antipsychotic Drugs in the Asia–Pacific Region
9. A review of current evidence for acetyl-l-carnitine in the treatment of depression
10. The association of personality trait on treatment outcomes in patients with chronic prostatitis/chronic pelvic pain syndrome: An exploratory study
11. Aripiprazole augmentation, antidepressant combination or switching therapy in patients with major depressive disorder who are partial- or non-responsive to current antidepressants: A multi-center, naturalistic study
12. Oxidative/nitrosative stress and antidepressants: Targets for novel antidepressants
13. Case–control association study of 14 variants of CREB1, CREBBP and CREM on diagnosis and treatment outcome in major depressive disorder and bipolar disorder
14. Association of estrogen receptor genes and schizophrenia: A preliminary study
15. A retrospective comparison of BMI changes and the potential risk factors among schizophrenic inpatients treated with aripiprazole, olanzapine, quetiapine or risperidone
16. Influence of TPH2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia
17. TAAR6 variations possibly associated with antidepressant response and suicidal behavior
18. Epistasis between a set of variations located in the TAAR6 and HSP-70 genes toward schizophrenia and response to antipsychotic treatment
19. Immediate versus gradual suspension of previous treatments during switch to aripiprazole: Results of a randomized, open label study
20. The impact of the CONSORT statement on reporting of randomized clinical trials in psychiatry
21. Psychometric Properties of the Patient Health Questionnaire–15 (PHQ–15) for Measuring the Somatic Symptoms of Psychiatric Outpatients
22. A Double-Blind, Randomized, Placebo-Controlled Trial of Paroxetine Controlled-Release in Irritable Bowel Syndrome
23. TAAR6 variation effect on clinic presentation and outcome in a sample of schizophrenic in-patients: An open label study
24. Association of the trace amine associated receptor 6 ( TAAR6) gene with schizophrenia and bipolar disorder in a Korean case control sample
25. Validation of the Patient Health Questionnaire-9 Korean version in the elderly population: the Ansan Geriatric study
26. Therapeutic implication of cocaine- and amphetamine-regulated transcript (CART) in the treatment of depression
27. Therapeutic possibilities of cysteamine in the treatment of schizophrenia
28. Potential role of lymphotoxin-alpha (tumor necrosis factor-beta) in the development of schizophrenia
29. Association of the serotonin transporter gene polymorphism with Korean male alcoholics
30. fMRI investigation on cue-induced smoking craving
31. TNFB polymorphism may be associated with schizophrenia in the Korean population
32. Polymorphism of CTLA-4 gene at position 49 of exon 1 may be associated with schizophrenia in the Korean population
33. SU99 - EXPLORATORY FINDINGS MAY IMPLICATE GENE'S VARIANTS, RELATED TO ANTIPSYCHOTIC MECHANISMS OF ACTION, WITH SCHIZOPHRENIA PSYCHOPATHOLOGICAL FEATURES
34. Case-control association study of 36 single-nucleotide polymorphisms within 10 candidate genes for major depression and bipolar disorder
35. Mixed depression: A study of its phenomenology and relation to treatment response
36. T31 - Genes Involved In Neurodevelopment, Neuroplasticity And Bipolar Disorder: Cacna1c, Chrna1 And MAPK1
37. M44 - Investigation of Genetic Variants Within Genes Targets of Antipsychotic Response And Their Signal Cascade In Schizophrenia And Antipsychotic Response
38. Influence of DAOA gene variants on antipsychotic response after switch to aripiprazole
39. CHAPTER 52 - ANXIETY
40. Does minocycline have antidepressant effect?
41. Additive effect between quinine oxidoreductase gene ( NQO1: Pro187Ser) and manganese superoxide dismutase gene ( MnSOD: Ala-9Val) polymorphisms on tardive dyskinesia in patients with schizophrenia
42. Manganese superoxide dismutase (MnSOD: Ala–9Val) gene polymorphism may not be associated with schizophrenia and tardive dyskinesia
43. Quinone oxidoreductase ( NQO1) gene polymorphism may not confer a susceptibility to mood disorders
44. Poster #S140 THE INFLUENCE OF AHI1 VARIANTS ON THE DIAGNOSIS AND TREATMENT OUTCOME IN SCHIZOPHRENIA
45. Monocyte chemoattractant protein-1 (MCP1) promoter -2518 polymorphism may confer a susceptibility to major depressive disorder in the Korean population
46. Poster #104 ASSOCIATION OF ESTROGEN RECEPTOR GENES AND SCHIZOPHRENIA: A PRELIMINARY STUDY
47. Paliperidone-associated atypical neuroleptic malignant syndrome: A case report
48. CONTRIBUTORS
49. Corrigendum to: “TAAR6 variation effect on clinic presentation and outcome in a sample of schizophrenic in-patients: An open label study” [Eur Psychiatr 2008;23:390–5]
50. P3-356: Decreased plasma antioxidants in patients with Alzheimer’s disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.